Global & France Laparoscopic Devices Market to 2031

The laparoscopic devices market in France is growing rapidly, largely driven by an increasing preference for minimally invasive surgeries among both medical professionals and patients. In 2022, minimally invasive techniques accounted for more than half of all surgical procedures performed in the country, rising significantly from 40% over the previous five years, which reflects a widespread and swift transition. Hospitals that have integrated robotic-assisted surgery have reported a 30% boost in operational efficiency along with a reduction in postoperative complications. Leading global companies like Medtronic and Intuitive Surgical are pivotal players in this market, regularly launching advanced devices that align with France’s healthcare goals of improving patient recovery, shortening hospital stays, and minimizing pain and scarring. Bariatric surgery has seen a dramatic rise in France over the last two decades, with the number of procedures climbing from 2,800 in 1997 to 52,500 in 2018. By 2022, the total bariatric surgeries performed reached 136,757, with sleeve gastrectomy emerging as the preferred technique, overtaking adjustable gastric banding since 2010. This reflects a sustained high volume of bariatric surgeries primarily performed using minimally invasive methods. In general surgery, minimally invasive techniques are widely adopted as well; for example, in 2020, approximately 62,206 laparoscopic appendectomies and 110,848 laparoscopic cholecystectomies were carried out, according to OECD data. The increasing number of surgeries and demand for minimally invasive devices are key factors driving growth in France’s general surgical devices market, with disposable surgical supplies contributing significantly to revenues. Colorectal surgery is also evolving toward less invasive options, supported by efforts to enhance early detection and treatment of colorectal cancer. Although recent detailed statistics on laparoscopic colorectal surgeries are limited, data from 2008 to 2014 showed a growing share of laparoscopic procedures for conditions such as pelvic organ prolapse, which often involve colorectal treatment. France’s national colorectal cancer screening program, which primarily relies on fecal immunochemical testing (FIT) and subsequent colonoscopies, indicates a robust framework and high patient participation that supports advanced endoscopic and laparoscopic procedures. For instance, in the PACA region, nearly 3.9 million colonoscopies were performed between 2013 and 2017, underscoring the extensive use of diagnostic and therapeutic endoscopy. In gynecology, robotic-assisted surgeries have risen sharply, supplementing conventional laparoscopic methods, with a significant increase in such procedures over the past five years. A national survey published in March 2025 on ResearchGate found that over 90% of gynecology residents felt confident performing laparoscopic adnexal surgeries and hysterectomies autonomously. This growing expertise in laparoscopic management of conditions like endometriosis and breast cancer is further fueling market expansion. Show more